Tenax Therapeutics, Inc.'s revenue was $0 in fiscal 2025. Over the last twelve months it was $0.
US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.
US$ thousands unless shown otherwise. Fiscal quarters.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
More: Health Care sector, rankings of US companies
Figures from Tenax Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tenax Therapeutics, Inc.
